An open trial of buspirone in the treatment of attention‐deficit disorder
- 4 August 2003
- journal article
- clinical trial
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 18 (6), 489-492
- https://doi.org/10.1002/hup.511
Abstract
Objective: Medications such as clonidine have been shown to facilitate calming, to enhance frustration tolerance, and to reduce aggression in attention deficit disorder (ADD) patients. The use of buspirone was studied as an alternative because of its longer excretion half‐life, decreased sedative side effects and more selective binding profile.Method: Eight psychiatric outpatients diagnosed with ADD were rated at baseline and while taking buspirone to determine its efficacy as a treatment for ADD. Comparisons of Wender‐Utah ratings within subject were used to measure behavioural changes in the subjects.Results: During buspirone treatment, the patients' mean scores improved significantly overall and in hyperactivity, inattention and immaturity factors.Conclusions: This preliminary study indicates that buspirone might be a beneficial and useful treatment of ADD, reducing hyperactive behaviours and enabling greater attentional ability with minimal side effects. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 10 references indexed in Scilit:
- Attention Deficit Disorder and Methylphenidate: Normalization Rates, Clinical Effectiveness, and Response Prediction in 76 ChildrenJournal of the American Academy of Child & Adolescent Psychiatry, 1994
- The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]American Journal of Psychiatry, 1993
- Clonidine enhances delayed matching-to-sample performance by young and aged monkeysPharmacology Biochemistry and Behavior, 1991
- Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disordersAmerican Journal of Psychiatry, 1991
- Separation of DSM-III attention deficit disorder and conduct disorder: evidence from a family-genetic study of American child psychiatric patientsPsychological Medicine, 1991
- Clonidine in Child and Adolescent PsychiatryJournal of Child and Adolescent Psychopharmacology, 1990
- Neuroendocrine effects of buspirone in patients with generalized anxiety disorderAmerican Journal Of Medicine, 1986
- α 2 -Adrenergic Mechanisms in Prefrontal Cortex Associated with Cognitive Decline in Aged Nonhuman PrimatesScience, 1985
- Clonidine Benefits Children with Attention Deficit Disorder and Hyperactivity: Report of a Double-Blind Placebo-Crossover Therapeutic TrialJournal of the American Academy of Child Psychiatry, 1985
- Factors associated with children’s adherence to stimulant medication.American Journal of Orthopsychiatry, 1982